|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Asset impairment charges | |||||
| Distributions, net of equity in earnings of unconsolidated affiliates | |||||
| Loss from mark-to-market adjustment on investment | |||||
| Gains on sales of investments | |||||
| Increase in provision for credit losses | |||||
| Deferred income tax (benefit) expense | |||||
| Non-cash stock-based compensation | |||||
| Other non-cash adjustments, net | |||||
| Changes in assets and liabilities, net of non-cash transactions: | |||||
| Accounts, notes and retainage receivable | |||||
| Contract assets | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses, insurance and other non-current liabilities | |||||
| Contract liabilities | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of and insurance settlements related to property and equipment | |||||
| Cash paid for asset acquisitions | |||||
| Cash paid for acquisitions, net of cash, cash equivalents and restricted cash acquired | |||||
| Investments in unconsolidated affiliates and other | |||||
| Proceeds from the sale or settlement of certain investments | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Borrowings under credit facility and commercial paper program | |||||
| Payments under credit facility and commercial paper program | |||||
| Proceeds from notes offerings | |||||
| Net proceeds from notes offering | |||||
| Payments related to senior notes | |||||
| Payments of contingent consideration liabilities recorded at acquisition date | |||||
| Payments related to tax withholding for stock-based compensation | |||||
| Payments of dividends | |||||
| Repurchase of common stock | |||||
| Other, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
Loading...